Discontinued — last reported Q4 '25
KLA Corporation Business Sale Proceeds decreased by 200.0% to -$161.00K in Q2 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2024), Business Sale Proceeds shows a downward trend with a -100.0% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $75.36M | -$75.36M | $0.00 | $75.36M | -$75.36M | $75.36M | $0.00 | $0.00 | $161.00K | -$161.00K | $0.00 | $161.00K | -$161.00K |
| QoQ Change | — | — | — | -200.0% | +100.0% | — | -200.0% | +200.0% | -100.0% | — | — | -200.0% | +100.0% | — | -200.0% |
| YoY Change | — | — | — | — | — | — | -200.0% | +200.0% | — | -100.0% | +100.2% | -100.2% | — | +200.0% | — |